| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |